Performance of the dentogingival junction with mta and biodentine on the treatment of invasive cervical resorptions. A literature review and case report.
Clicks: 198
ID: 264710
2021
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
196 views
9 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Invasive cervical resorption (ICR) is an uncommon phenomenon (0.1%), however, it represents a challenge to the structural and functional integrity of the dentogingival junction, as well as a risk for the survival of the affected tooth. They are characterized by their location and invasive character, being able to appear in any tooth of the permanent dentition. It shows up after the damage to the cervical insertion apparatus, leaving the pulp without participation in the origin of the lesion. They may appear just below the junctional epithelium or at a more apical level. The MTA® (Dentsply, Tulsa dental, Tulsa OK) and the Biodentine® (Septodent, Saint Maur of Fossés, France) are two biomaterials that have demonstrated the ability to promote the neoformation of cement so they are considered an alternative in the treatment of the ICR. This article presents an ICR clinical cases treated with these biomaterials, in which favorable post-operative healing is observed. MTA, Biodentine, biomaterials, root resorption, invasive cervical resorption.
| Reference Key |
ginguerra2021performancejournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Gión-Guerra, Beatriz;Pérez-Lanza, Pablo;Almiñana-Pastor, Pedro;Micó-Martínez, Pau;Alpiste-Illueca, Francisco M;López-Roldán, Andrés; |
| Journal | Journal of clinical and experimental dentistry |
| Year | 2021 |
| DOI |
10.4317/jced.57410
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.